The size of the global blood screening market is predicted to reach USD 3.24 billion by the year 2025 from valuing USD 2.08 billion in 2020, growing at a CAGR of 9.3% during the forecast period 2020 to 2025.
The market is exhibiting obvious potential in the specified gauging period. The market keeps on picking up the energy with the quick increment in the reception of these devices among patients and dispatch of mechanically propelled, easy to understand devices into the market.
Blood screening is a process where various blood tests are carried out to diagnose multiple infectious diseases like HIV, AIDS, and others.
The nucleic acid amplification test was initially introduced in six European countries France, Germany, Italy, and Spain, the UK, and Switzerland in the early 1999 and 2001. Blood donation among the people has increased from 3.4% in 2008 to 3.6% to 2010. Nearly 2million people donate blood regularly in Germany every year.
MARKET DRIVERS
Increasing blood donations among people is one of the significant factors propelling the global blood screening market during the forecast period. Growing need to diagnose samples along with increasing infectious diseases is elevating the demand of the market. The government has taken so many initiatives in bringing awareness among the people related to donating blood and also screening before transfusion, which accelerates the blood screening market growth.
The Blood Screening Market is expected to grow rapidly shortly and to provide lucrative growth opportunities such as the emergence of microbiology screening, multiplexing, and pathogen reduction technologies. Also, factors like increasing economies of developing nations and technological improvements are expected to offer another set of opportunities for the growth of the market.
MARKET RESTRAINTS
The primary factor which is restraining the blood screening market is the high cost, which needed to be reduced. Lack of awareness among the people about donating blood may also hamper the market growth. Lack of lab technicians among the hospitals and clinical laboratories may also restrict the market growth over the review period. Strict regulations for the approval of new screening devices into the market over the analysis period may limit the growth. The availability of other alternative technologies like digital immunoassays restricts the blood screening market growth over the period.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analysed |
By Technology, Product, End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This research report on the global blood screening market has been segmented and sub-segmented based on the technology, product, end-user, and region.
Blood Screening Market - By Technology:
Based on technology, the nucleic acid amplification segment is ruling the blood screening market owing to factors like the increasing applications of NAT technology, and the growing number of blood donations.
The Elisa segment is expected to occupy the second-largest share in the blood screening market over the period, which is due to low cost and standard increase of infectious diseases.
Blood Screening Market - By Product:
Based on the product, the reagents & kits segment is accounted for the largest share and is to maintain its dominance over the period. Cost-effectiveness and specificity in examining the appearance of various elements, drives the segment of this market to the extent.
The instruments segment is accounted for the highest share in the market due to the introduction of new devices into the market by key players.
Blood Screening Market - By End User:
Based on end-user, the blood bank segment is contributing a significant share of the revenue. It is likely to grow further during the forecast period owing to factors like an increasing number of organ transplantation surgeries, increasing awareness about blood donation and safety, increasing investments from private and public organizations.
Blood Screening Market – By Region:
Regionally, North America accounted for the majority of the global market share in 2019 owing to the existence of a large number of key players and the acquisition of blood screening procedures. In this region, the US is expected to lead the blood screening market due to advanced technologies in making use of these for screening.
Europe occupies the second-largest share in the blood screening market over the analysis period due to factors like the growing number of steps taken by the government and other organizations in blood donations, screening & transfusion activities over different countries over the period. Germany is projected to hold the largest share in the blood screening market. It is estimated to maintain its position over the period due to growth in awareness about blood donation in the country of this region.
At the same time, Asia-Pacific is expected to have a quick and fast growth rate in the blood screening market over the analysis period. The market growth owes to the growing number of blood donations, a moderate increase of new pathogens, and a great appearance of high-quality infrastructure towards clinical and hospital laboratories in the blood screening market during the period. China, Japan, and India are the significant contributors in the blood screening market over the period due to the increasing concentration of key players in existing countries.
The blood screening market of the Latin America region is considered to have stable and steady growth over the period, which owes to government initiatives in bringing awareness among the people, and growing awareness about the safety of the blood are bolstering the market growth of this region. Mexico is leading the market and continues its dominance over the period followed by Brazil and Argentina.
The blood screening market of the Middle East & Africa region is projected to have a slow and least share due to the growing number of blood donations. Also, factors like cost, strict government regulations for the product approval of new screening devices may hamper the blood screening market growth during the forecast period. UAE, Africa, GCC, KSA, and other countries are majorly contributing to the market.
TOP COMPANIES IN THE MARKET
Most promising companies dominating the Global Screening Market profiled in this report are Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols, Siemens AG, and Beckman Coulter, Inc
RECENT MARKET DEVELOPMENTS
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Nucliec Acid Amplification Test
6.3.1 Transcription-Mediated Amplification (TMA)
6.3.2 Real-Time Polymerase Chain Reaction (PCR
5.1.2 rCPR
5.1.3 ELISA
5.1.3.1 ELISA Market, By Platform
5.1.3.1.1 Chemiluminescence Immunoassay (CLIA)
5.1.3.1.2 Fluorescence Immunoassay (FIA)
5.1.3.1.3 Colorimetric Immunoassay (CI)
5.1.3.2 ELISA Market, By Generation
5.1.3.2.1 First-Generation ELISA
5.1.3.2.2 Second-Generation ELISA
5.1.3.2.3 Third-Generation ELISA
5.1.3.2.4 Fourth-Generation & Above
5.1.4 CLIA
5.1.5 Flourescence Assay
5.1.6 Rapid Test
5.1.7 NGS
5.1.8 Western Blotting
5.1.9 Y-o-Y Growth Analysis, By Technology
5.1.10 Market Attractiveness Analysis, By Technology
5.1.11 Market Share Analysis, By Technology
5.2 Product
5.2.1 Instrument
5.2.1.1 Rental Purchase
5.2.1.2 Outright Purchase
5.2.2 Reagent and Kits
5.2.2.1 NAT Reagents & Kits
5.2.2.1.1 Enzymes and Polymerases
5.2.2.1.2 Standards and Controls
5.2.2.1.3 Probes and Primers
5.2.2.1.4 Buffers, Nucleotides and Solutions
5.2.2.1.5 Labeling and Detection Reagents
5.2.2.2 ELISA Reagents & Kits
5.2.2.2.1 Immunosorbents
5.2.2.2.2 Controls
5.2.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)
5.2.2.2.4 Substrates (Of Enzymes)
5.2.2.2.5 Sample Diluents and Wash Solutions
5.2.3 Software
5.2.4 Y-o-Y Growth Analysis, By Product
5.2.5 Market Attractiveness Analysis, By Product
5.2.6 Market Share Analysis, By Product
5.3 End User
5.3.1 Blood Bank
5.3.2 Hospital
5.3.3 Y-o-Y Growth Analysis, By End User
5.3.4 Market Attractiveness Analysis, By End User
5.3.5 Market Share Analysis, By End User
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Grifols
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific
8.3 Roche Diagnostics
8.4 BioMerieux
8.5 Bio-Rad Laboratories
8.6 Siemens Heathineers
8.7 Abbott Laboratories
8.8 Ortho Clinical diagnostics
8.9 Becton
8.10 Dickinson and Company
8.11 Beckman Coulter
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
Related Reports
